While there is no definitively established direct mechanism by which GLP-1 receptor agonists cause fatigue, several biological pathways warrant consideration
It can help with various aspects of health, including improving muscle structure, enhancing body composition by reducing body fat, and promoting youthful anatomy
Semaglutide for Weight Loss: What the SURMOUNT-5 Results Mean for Northwest Louisiana Patients For the first time, a major clinical trial put tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy) head to head in people with obesity who do not have diabetes, and the results landed in the New England Journal of Medicine in May 2025.[1] The short answer: tirzepatide produced significantly more weight loss
Due to the lack of targeted research, its not possible to definitively determine whether GLP-1 drugs are completely safe or unsafe for those with hemophilia
By modifying polymer composition, crosslinking density, or incorporation of functional moieties, hydrogels can be engineered with precise mechanical stiffness, porosity, and swelling behavior [131]
Mounjaro is FDA approved for Type 2 diabetes but is prescribed off-label (for a non-FDA-approved use) for weight loss